title: Can Patient Risk Factors Outperform Antiemetic Guidelines?: Choosing Wisely.
authors.affiliation: Princess Margaret Cancer Centre, Department of Medical Oncology, University of Toronto, Toronto, Ontario, Canada.
authors.forename: David
authors.initials: D
authors.lastname: Warr
authors.affiliation: Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada3Department of Pharmacy, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Carlo
authors.initials: C
authors.lastname: DeAngelis
authors.affiliation: Sunnybrook Odette Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Edward
authors.initials: E
authors.lastname: Chow
mesh_terms: D000932:Antiemetics / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003661:Decision Support Techniques; D005260:Female; D006801:Humans; D009325:Nausea / Q000517:prevention & control*; D010818:Practice Patterns, Physicians'; D014839:Vomiting / Q000517:prevention & control*
chemical_list: D000932:Antiemetics